Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Spectral Medical's share price for the quarter that ended in Dec. 2023 was $0.32. Spectral Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 278.58 Mil. Therefore, Spectral Medical's market cap for the quarter that ended in Dec. 2023 was $89.14 Mil.
Spectral Medical's quarterly market cap
declined
from Jun. 2023 ($71.69 Mil) to Sep. 2023 ($70.40 Mil) but then
increased
from Sep. 2023 ($70.40 Mil) to Dec. 2023 ($89.14 Mil).
Spectral Medical's annual market cap
increased
from Dec. 2021 ($47.09 Mil) to Dec. 2022 ($74.68 Mil) and
increased
from Dec. 2022 ($74.68 Mil) to Dec. 2023 ($89.14 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Spectral Medical's Enterprise Value for Today is $99.90 Mil.
Spectral Medical Market Cap Historical Data
The historical data trend for Spectral Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Spectral Medical's Market Cap
For the Diagnostics & Research subindustry, Spectral Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral Medical's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Spectral Medical's Market Cap falls into.
Spectral Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Spectral Medical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral Medical (OTCPK:EDTXF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Spectral Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Spectral Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Spectral Medical (Spectral Medical) Business Description
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EDTXF has been successfully added to your 